These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 6314570

  • 21. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 22. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 23. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB.
    J Exp Med; 1997 May 05; 185(9):1605-17. PubMed ID: 9151898
    [Abstract] [Full Text] [Related]

  • 24. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP, Alekberova ZS, Barinskii IF, Nasonova VA.
    Ter Arkh; 1983 May 05; 55(7):140-6. PubMed ID: 6312625
    [No Abstract] [Full Text] [Related]

  • 25. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ, Wallace LE, Rickinson AB, Epstein MA.
    Eur J Immunol; 1981 Sep 05; 11(9):686-93. PubMed ID: 6170517
    [Abstract] [Full Text] [Related]

  • 26. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM.
    Acta Haematol Pol; 1979 Sep 05; 10(3):183-91. PubMed ID: 228518
    [No Abstract] [Full Text] [Related]

  • 27. Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation.
    Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS.
    Cell Immunol; 1980 Dec 05; 56(2):518-25. PubMed ID: 6258810
    [No Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus.
    Rickinson A.
    Virus Res; 2002 Jan 30; 82(1-2):109-13. PubMed ID: 11885937
    [No Abstract] [Full Text] [Related]

  • 29. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Jan 30; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 30. Immune surveillance against Epstein-Barr virus.
    Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB.
    Semin Immunol; 1992 Apr 30; 4(2):97-104. PubMed ID: 1377517
    [Abstract] [Full Text] [Related]

  • 31. Epstein-Barr virus and rheumatoid arthritis.
    Bluestein HG, Hasler F.
    Surv Immunol Res; 1984 Apr 30; 3(1):70-7. PubMed ID: 6326237
    [No Abstract] [Full Text] [Related]

  • 32. Infectious mononucleosis: model for self-limiting lymphoproliferation.
    Carter RL.
    Lancet; 1975 Apr 12; 1(7911):846-9. PubMed ID: 48066
    [Abstract] [Full Text] [Related]

  • 33. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
    Burrows SR, Misko IS, Sculley TB, Schmidt C, Moss DJ.
    J Virol; 1990 Aug 12; 64(8):3974-6. PubMed ID: 1695259
    [Abstract] [Full Text] [Related]

  • 34. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA).
    Garzelli C, Pacciardi A, Carmignani M, Conaldi G, Basolo F, Falcone G.
    Immunol Lett; 1989 Sep 12; 22(3):211-6. PubMed ID: 2478456
    [Abstract] [Full Text] [Related]

  • 35. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 36. Role of T cell subpopulations in the control of the proliferative potential of EBV transformed B cells.
    Masucci MG, Klein E.
    Behring Inst Mitt; 1983 May 01; (72):163-8. PubMed ID: 6152688
    [No Abstract] [Full Text] [Related]

  • 37. The pathogenesis of infectious mononucleosis.
    McCue JD.
    Hosp Pract (Off Ed); 1982 Oct 01; 17(10):34, 34A-F, 34J-M. PubMed ID: 6288544
    [No Abstract] [Full Text] [Related]

  • 38. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK, Stroehmann I, Brandis H.
    Nature; 1980 Aug 14; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract] [Full Text] [Related]

  • 39. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP, DeMars R, Hank JA, Sondel PM.
    Cell Immunol; 1988 Sep 14; 115(2):363-72. PubMed ID: 2842068
    [Abstract] [Full Text] [Related]

  • 40. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.
    Tsoukas CD, Carson DA, Fong S, Slovin SF, Fox RI, Vaughan JH.
    Clin Immunol Immunopathol; 1982 Jul 14; 24(1):8-14. PubMed ID: 6179673
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.